Safety of and Immune Response to Two HIV Vaccines: SAAVI DNA-C2 Boosted With SAAVIMVA-C, in HIV-Negative Adults

This study is ongoing, but not recruiting participants.

Study NCT00574600 Information provided by National Institute of Allergy and Infectious Diseases (NIAID)

First Received: December 13, 2007 Last Updated: March 10, 2011 History of Changes

No Study Results Posted on ClinicalTrials.gov for this Study

Study Status:	This study is ongoing, but not recruiting participants.
Estimated Study Completion Date:	No date given
Estimated Primary Completion Date:	No date given